OR WAIT null SECS
Susan Haigney is lead editor of BioPharm International®.
May 17, 2023
The report outlines highlights from the agency’s medicines evaluations and milestones for 2022.
May 10, 2023
EMA and European regulators are lifting their COVID-19 business continuity measures as the pandemic’s peak ends.
April 28, 2023
The event, cosponsored by FDA and USP, hosted regulators and industry leaders to discuss the challenges in strengthening the medical product supply chain.
March 22, 2023
In addition to a new interim president, the company is opening new microbial capacity at its San Antonio facility and has plans to construct a commercial-scale facility in Manhattan, Kan.
March 15, 2023
Manual aseptic operations make quality practices necessary in the manufacturing of compounded drugs.
March 03, 2023
The ability of artificial intelligence to process large amounts of diverse data cleanly creates more accurate reports for improved drug safety.